Core Viewpoint - Quantum BioPharma Ltd. announces the expiration of 53,147 warrants and reiterates the record date for the distribution of contingent value rights (CVRs) to shareholders, linked to ongoing litigation against financial institutions for alleged stock price manipulation [1][2][3]. Group 1: Warrants Expiration - The company has expired 53,147 warrants, which were part of a previous financing completed on October 20, 2020, and represents the last tranche issued to hedge funds and investment funds [1]. - The original number of warrants issued was 3,454,543 before a reverse stock split of 65 to 1 [1]. Group 2: Contingent Value Rights (CVRs) - The record date for the distribution of CVRs is set for October 27, 2025, on a one-for-one basis for holders of Class B Subordinate Voting Shares [2]. - Each CVR will entitle holders to a pro rata portion of a minimum of 10% and up to 50% of the net proceeds from the company's legal action against CIBC World Markets, RBC Dominion Securities, and others, which seeks damages exceeding USD $700 million [3][4]. - Payments under the CVRs will only occur if the company receives net proceeds from the litigation, and there is no guarantee that any proceeds will be received [5][8]. Group 3: Company Overview - Quantum BioPharma is focused on developing innovative assets and biotech solutions for neurodegenerative and metabolic disorders, with drug candidates at various stages of development [6]. - The company’s lead compound, Lucid-MS, is designed to prevent and reverse myelin degradation, a key mechanism in multiple sclerosis, and is currently in preclinical models [6]. - Quantum BioPharma retains a 20.10% ownership stake in Unbuzzd Wellness Inc., which is involved in the development of health products, and has a royalty agreement that provides 7% of sales until total payments reach $250 million, after which the royalty rate drops to 3% [6].

Core Viewpoint - FG Nexus announced the approval of a distribution payment of $10 per contingent value right (CVR) to be initiated on September 17, 2025, marking the first cash distribution from the CVR Trust [2][3]. Group 1: Distribution Details - The initial cash distribution from the CVR Trust is the first of potential additional distributions expected over time [3]. - Future distributions may be made in cash or in-kind securities as the CVR Trust works to monetize and distribute proceeds from its asset liquidation [4]. Group 2: CVR Trust Management - The CVR Trust was established by FG Nexus on August 8, 2025, and is managed by a committee that includes D. Kyle Cerminara and Larry G. Swets, focusing on asset liquidation and monetization over the next three years [6]. - The CVR Trust holds various assets, including cash, the net assets of Strong Technical Services, and equity interests in multiple companies [4]. Group 3: CVR Holder Information - Beneficial holders of CVRs will receive distribution payments directly through their bank or broker, while registered holders will receive payments via US mail [5]. - The CVRs are not transferable, will not be certificated, and will not be listed for trading on any exchange [6].